US FDA approves Lilly and Incyte’s Olumiant for treating certain hospitalised patients with…
Olumiant is the first and only FDA-approved JAK inhibitor for the treatment of COVID-19 in certain hospitalised adults requiring…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
OLUMIANT
US FDA adds strict safety warnings on arthritis drugs from Pfizer, AbbVie and Lilly
The US Food and Drug Administration's boxed warnings on the labels of Rinvoq , Xeljanz and Olumiant flags the risk of…
Baricitinib in combination with remdesivir reduces recovery time in hospitalised COVID-19 patients:…
Data from the Adaptive COVID-19 Treatment Trial (ACTT-2) revealed an approximately one-day reduction in median recovery time for…